NIKITA Drug Patent Profile
✉ Email this page to a colleague
When do Nikita patents expire, and when can generic versions of Nikita launch?
Nikita is a drug marketed by Lupin Ltd and is included in one NDA.
The generic ingredient in NIKITA is pitavastatin sodium. There are fifteen drug master file entries for this compound. Additional details are available on the pitavastatin sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NIKITA?
- What are the global sales for NIKITA?
- What is Average Wholesale Price for NIKITA?
Summary for NIKITA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Patent Applications: | 4,743 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NIKITA at DailyMed |
US Patents and Regulatory Information for NIKITA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin Ltd | NIKITA | pitavastatin sodium | TABLET;ORAL | 209875-001 | Aug 4, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lupin Ltd | NIKITA | pitavastatin sodium | TABLET;ORAL | 209875-002 | Aug 4, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lupin Ltd | NIKITA | pitavastatin sodium | TABLET;ORAL | 209875-003 | Aug 4, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |